| Resta et al.[41] | Giardiello et al.[42] |
---|---|---|
Study design | Retrospective cohort study | Meta-analysis |
Any cancer | 15.1 (CI 10.5-21.2) | 15.2 |
Breast | 12.5 (CI 5.1-26.0) | 15.2 |
Cervix | 55.6 (CI 17.7-134.0) | 1.5 |
Gynaecological cancers | 27.7 (CI 11.3-57.6) | NA |
Colorectal cancer | 13.5 (CI 4.3-32-5) | 84.0 (Colon) |
Pancreas | 139.7 (CI 61.1-276.4) | 132 |
Gastrointestinal cancer | 126.2 (CI 73.3-203.4) | NA |
Ovary | NA | 27.0 |
Uterus | NA | 16.0 |
Testes | NA | 4.5 |
Lung | NA | 17.0 |
Small intestines | NA | 520.0 |
Stomach | NA | 213.0 |
Oesophagus | NA | 57.0 |